Ardelyx (ARDX) Stock
Ardelyx (ARDX) closed at $3.18 on Nov 17, 2026; its Tenet Score is 46 of 100 against 340 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $3.18
- Nov 17, 2026
- Market cap
- $771.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 2.80 – 8.40
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 46/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Ardelyx Inc scores 46/100. Mixed. Quality is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Corvus Pharmaceuticals IncCRVS | 52 | $894.1M |
| Pharming Group N.V.PHAR | 40 | $883.4M |
| MeiraGTx Holdings plcMGTX | 69 | $854.2M |
| Syndax Pharmaceuticals IncSNDX | 49 | $815.3M |
| Collegium Pharmaceutical IncCOLL | 60 | $790.2M |
| Monte Rosa Therapeutics IncGLUE | 66 | $782.7M |
| Lexicon Pharmaceuticals IncLXRX | 41 | $779.2M |
| Annexon IncANNX | 37 | $733.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
Common questions
What sector and industry is Ardelyx in?
Ardelyx is in the Healthcare sector and the Drugs industry.
What is Ardelyx's Tenet Score?
Ardelyx's Tenet Score is 46 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




